Androgen Receptor Expression Is Usually Maintained in Initial Surgically-Resected Breast Cancer Metastases, but Often Lost in Terminal Metastases Found at Autopsy.
A Cimino-Mathews, J Hicks, A DeMarzo, BH Park, P Argani - The Johns Hopkins Hospital, Baltimore, MD
Ductal Carcinoma (DCIS) in Young Women: A Study of the Pathological and Immunohistochemical Features of Pure DCIS in Women <40 Years of Age.
H Elwood, H Nassar-Warzecha - The Johns Hopkins Hospital, Baltimore, MD
The 8p11.2 Amplicon Is Associated with Hormonal Treatment Resistance and a Worse Clinical Outcome: Validation by FISH, aCGH and Gene Expression Profiling.
AA Gru, AL Salavaggione, J Snyder, Y Tao, J Hoog, MJ Ellis, C Allred - Washington University School of Medicine, St. Louis, MO
A Follow-Up Study of 283 Patients Diagnosed with Papillary Lesions of the Breast.
H Arabi, S Bandyopadhyay, B Albashiti, H Skeirek, S Yadam, Y Hussein, A Almradi, R Ali-Fehmi - Wayne State Univ, Detroi, MI
Core Biopsy Diagnosis vs. Excision Diagnosis of Papillary Lesions of the Breast: The Impact of Breast Pathology Subspecialization.
K Jakate, M Debrot, FP O'Malley, AM Mulligan - University of Toronto, ON, Canada; St. Michael's Hospital, Toronto, Canada
Organotropism and Prognostic Marker Discordance in Distant Metastases of Breast Carcinoma: Fact or Fiction? A Clinicopathologic Analysis.
PE St. Romain, R Madan, OW Tawfik, I Damjanov, F Fan - University of Kansas Medical Center, Kansas City
Cold Ischemia Time: Effect on HER2 Detection by In-Situ Hybridization and Immunohistochemistry.
BP Portier, E Downs-Kelly, JJ Rowe, D Patil, GT Budd, C Lanigan, Z Wang, D Hicks, DL Rimm, RR Tubbs - Cleveland Clinic, OH; Taussig Cancer Institute, Cleveland, OH; University of Rochester, NY; Yale University, New Haven, CT
Distribution of Estrogen Receptor (ER) Staining by Image Analysis in a Large Cohort of Breast Cancer Cases: Results from the Nurses' Health Study.
G Williams, R Hu, R Tamimi, L Collins - Beth Israel Deaconess Medical Center, Boston; Channing Laboratory, Brigham and Women's Hospital, Boston
Is Estrogen Receptor Assessment Necessary in Well Differentiated Invasive Ductal Carcinomas (IDCs) Graded by the Nottingham Combined Histologic Scoring System?
AL Klein, JA Hanson, A Goodwin, DL Weaver, AB Ambaye - Fletcher Allen Health Care, Burlington, VT; University of Vermont, Burlington
Basal Marker Reactivity in Triple Negative Breast Carcinomas Does Not Predict Pathologic Complete Response Following Neoadjuvant Chemotherapy.
JA Kraus, S Beriwal, DJ Dabbs, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Poly (ADP-ribose) Polymerase (PARP)-1 Expression in BRCA1-Associated Breast Cancers: Relationship to Estrogen Receptor (ER) Status.
JS Kaplan, S Schnitt, L Collins, K Fetten, V Villegas-Bergazzi, KM Sprott, N Tung - Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA; On-Q-ity, Waltham, MA
Triple Negative Breast Carcinoma in African American vs. Caucasian Populations: Clinicopathologic Parameters, Marker Expression, and Outcome.
HC Sullivan, A Adams, GM Oprea, AJ Page, C Cohen - Emory University, Atlanta, GA
Survivin Expression in Estrogen Receptor-Positive and Triple Negative Invasive Breast Carcinoma: Correlation with Clinicopathologic Features.
KD Bohman, C Cohen, HC Sullivan, B Zbytek, AL Adams - Emory University, Atlanta, GA
EZH2 Expression in Triple Negative Breast Carcinoma.
Y Hussein, S Bandyopadhyay, B Albashiti, A Almradi, Z Nahleh, T Jazaerly, H Jaratli, R Ali-Fehmi - Wayne State University, Detroit, MI; Karmanos Cancer Institute, Detroit, MI; Detoit Medical Center, Detroit, MI
Chromosomal 7 and 17 Polysomy in Triple Negative Invasive Breast Carcinoma.
C Velosa, P Storto, JF Silverman, U Krishnamurti - West Penn Hospital, Pittsburgh, PA; Allegheny General Hospital, Pittsburgh, PA
Claudin-Low Breast Cancer: A Novel Subtype Associated with Basal-Like Phenotype and Metaplastic Breast Cancer.
S Lu, K Singh, S Mangray, R Tavares, L Noble, RA DeLellis, - M Resnick, E Yakirevich
Alpert Medical School of Brown University, Providence, RI
Measurement of Residual Cancer Burden in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Correlation with Biomarker Expression and Molecular Subtypes.
A Cockburn, Y Peng, D Euhus, B Haley, V Sarode - University of Texas Southwestern, Dallas
Classification by Molecular Subtypes of 70 Male Breast Carcinomas According to Immunohistochemical Profile.
NE Fuehrer, AM Locante, JS Scow, JC Boughey, SS Shah, CA Reynolds, RE Jimenez - Mayo Clinic, Rochester, MN
Morphologic and Immunohistochemistry (IHC) Profile of Luminal A Subtype Breast Cancer Patients with Recurrence and Non-Recurrence: A Single Institution Retrospective Review Study with 10 Year Follow-Up.
S Hooda, G Carter, A Brufsky, R Jankowitz, P Badve, M Chivukula - University of Pittsburgh Medical Center, PA